Atlas Trials

Study on Safety, Tolerability and Immunogenicity of an MVA Vaccine Administered to Healthy Subjects

Clinical trial NCT00189943 · COMPLETED

Trial details

NCT number
NCT00189943
Sponsor
Bavarian Nordic
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Smallpox
Start date
2001-04-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.